Over the next two years a number of clinical trials will be concluding and it is hoped these will be instrumental in further improving our understanding of Parkinson's. In addition, there could be benefits for the affected community where trials actually succeed. But as the author of the article Rosie Taylor points out, we must err on the side of caution...

Read the full article.